9IWV image
Entry Detail
PDB ID:
9IWV
Keywords:
Title:
Crystal structure of Lsd18 after incubation with the substrate
Biological Source:
Source Organism:
Host Organism:
PDB Version:
Deposition Date:
2024-07-26
Release Date:
2025-04-16
Method Details:
Experimental Method:
Resolution:
1.85 Å
R-Value Free:
0.23
R-Value Work:
0.18
R-Value Observed:
0.19
Space Group:
P 1
Macromolecular Entities
Polymer Type:polypeptide(L)
Description:Putative epoxidase LasC
Chain IDs:A, B
Chain Length:488
Number of Molecules:2
Biological Source:Streptomyces lasalocidi
Modified Residue
Compound ID Chain ID Parent Comp ID Details 2D Image
ELY A LYS modified residue
Primary Citation
Mechanistic and molecular insights into iterative triepoxidation catalyzed by monooxygenase MonCI using a natural substrate analog.
Int.J.Biol.Macromol. 311 142876 142876 (2025)
PMID: 40203940 DOI: 10.1016/j.ijbiomac.2025.142876

Abstact

Monensin, a polyether antibiotic produced by Streptomyces cinnamonensis, is synthesized through a series of stereospecific epoxidations orchestrated by the FAD-dependent monooxygenase MonCI. This study presents the crystal structure of MonCI in complex with a substrate analog, farnesyl acetate, which undergoes in vitro epoxidation at all three olefinic sites by MonCI. Additionally, we have solved the crystal structures of MonCI in complex with mono- and bis-epoxide intermediates. Structural analysis revealed that the interactions between MonCI and its substrate are predominantly hydrophobic, with residue Y208 playing a crucial role in substrate translocation. Computational modeling emphasizes the importance of FAD proximity to each olefinic group for efficient catalysis, providing insight into the mechanistic pathways for the first, second, and third epoxidations. Notably, when combined with electrochemical techniques, the yield of tri-epoxide farnesyl acetate reached 94 %, surpassing traditional enzymatic catalysis. This work not only elucidates the catalytic mechanism of MonCI but also underscores its potential as an effective biocatalyst for processive epoxidation in organic synthesis.

Legend

Protein

Chemical

Disease

Primary Citation of related structures